A nonsignificant trend towards higher cell proliferation in pathologically node-positive tumours was observed (pathologically node negative, median Ki-67 19.6%, node positive 25.8%; P =0.09).
← all phrases
“a nonsignificant trend”
Sighted at
p<0.1
In the literature
Two‐factor ANOVA shows significant reduction in depressive symptoms over time [ F (4, 270) = 30.36, p < .0001] with a nonsignificant trend toward lower scores in males throughout hospitalization [ F (1, 270) = 2.778, p = .09].
A nonsignificant trend group-by-treatment suggested that the effect of AMPT was stronger in participants with schizophrenia, corroborating our sub-hypothesis ( P = .09, supplementary table 3 ).
Nevertheless, regression analysis did not confirm this finding, although a nonsignificant trend was observed ( P =0.09).
This effect was further attenuated to a nonsignificant trend when adjusted for mental health and morbidity-related factors (SQ4: HR 1.25, 95% CI 0.97–1.63, P = 0.09; Model 4).
[ 15 – 17 ] A meta-analysis of 4 randomized controlled trials with 1130 patients (816 receiving pridopidine, 314 receiving placebo) found a nonsignificant trend favoring pridopidine in the Unified HD Rating Scale Total Motor Score (mean difference, −0.93; 95% CI, −2.01 to 0.14; P = .09).
Patients over 69 years were less likely to undergo decompression (OR 0.8, 95% CI [0.7-0.85], P < 0.001) and LFS (OR 0.6, 95% CI [0.5-0.6], P < 0.001), while patients under 50 years showed a nonsignificant trend toward decreased decompression risk (OR 0.9, 95% CI [0.7-1.02], P = 0.09) and increase LFS risk (OR 1.1, 95% CI [0.9-1.3], P = 0.5) ( Table 4 ).
There was a nonsignificant trend for HOMA index to improve ( P = 0.09).
Moreover, there was a nonsignificant trend towards an interaction of T1-T2 sequence and SOA, F (1, 31) = 2.99, p = .09, η p 2 = .09, suggesting faster responses with short than with long SOA in repetition trials (924 ms vs. 977 ms; t [31] = −2.93, p < .01, d = 0.14), but no RT differences across SOAs in switch trials (939 ms vs. 959 ms; t [31] = −1.38, p = .18, d = 0.06).
Encounters lasting >1 minute were rated significantly better (mean: 1.26 vs 1.60; P =0.033) than those lasting <1 minute, with a nonsignificant trend toward being rated more helpful (mean: 1.35 vs 1.66; P =0.09).
There was a nonsignificant trend on the MOCA, where the BG+ group scored worse than HC ( F (2,13) = 2.89, p = 0.09, partial η 2 = 0.31, large effect size (ES)).
A nonsignificant trend was identified in hypACT 5% group ( p = 0.09).
Mean achieved METs showed a nonsignificant trend toward lower values in the event group (10.92 ± 3.46 vs. 12.13 ± 2.38, p = 0.09); however, poor functional capacity (METs < 7) was significantly more prevalent among patients with events (15.4% vs. 2.6%, p = 0.022). 3.4.
A nonsignificant trend towards worse RFS was observed in patients with positive washings (HR 1.64; 95% CI 0.92–2.93; p = 0.091).
Findings for FTA showed a nonsignificant trend in the same direction as PIF ( r = −0.153, 95% CI, −0.322 to 0.025, t 120 = −1.70, p = .091).
The healthy dietary index demonstrated a nonsignificant trend toward a protective association ( p = 0.091).
The SpyDS group exhibited significantly lower log-NLR values at admission (estimate -0.996; p <0.001) and at discharge (estimate -0.668; p =0.019), with a nonsignificant trend toward lower values at the first outpatient visit (estimate -0.488; p =0.091).
normal BMI (IRR 1.12, 1.01–1.25; p = 0.039), whereas overweight/obesity showed a nonsignificant trend toward shorter stays (IRR 0.93, 0.84–1.02; p = 0.091).
Planned comparisons demonstrated that the same group decreased freezing throughout this time ( p = .006) and that a nonsignificant trend was observed in the opposite direction in the alternate group ( p = .091).
Diabetes mellitus showed a nonsignificant trend toward higher frequency in the ASD group [18 (33.3%) vs. 8 (18.2%); p = 0.091]. 3.4.
Results for CSF 2-AG revealed only a nonsignificant trend for interaction between CSF BE and CSF 2-AG ( P = .091), so this interaction was not pursued further.
In HBV/HIV, there was a nonsignificant trend toward lower CD4 T-cell counts in HBeAg-positive individuals ( P = .0913) ( Figure 2 E ).
There was a nonsignificant trend toward differing intervals between ptosis diagnosis and surgery ( P = 0.092).
Neoadjuvant therapy also demonstrated a nonsignificant trend toward worse outcomes with a HR of 3.347 (95% CI, 0.822-13.623; P = .092).
There was a nonsignificant trend for slightly faster procedural times in patients with meniscus sign (median time 33 min vs. 40 min, p = 0.092).